{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:09:06Z","timestamp":1793506146323,"version":"4.5.0"},"reference-count":252,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>As an effective treatment for diabetes, islet transplantation has garnered significant attention and research in recent years. However, immune rejection and the toxicity of immunosuppressive drugs remain critical factors influencing the success of islet transplantation. While immunosuppressants are essential in reducing immune rejection reactions and can significantly improve the survival rate of islet transplants, improper use of these drugs can markedly increase mortality rates following transplantation. Additionally, the current availability of islet organ donations fails to meet the demand for organ transplants, making xenotransplantation a crucial method for addressing organ shortages. This review will cover the following three aspects: 1) the immune responses occurring during allogeneic islet transplantation, including three stages: inflammation and IBMIR, allogeneic immune response, and autoimmune recurrence; 2) commonly used immunosuppressants in allogeneic islet transplantation, including calcineurin inhibitors (Cyclosporine A, Tacrolimus), mycophenolate mofetil, glucocorticoids, and Bortezomib; and 3) early and late immune responses in xenogeneic islet transplantation and the immune effects of triple therapy (ECDI-fixed donor spleen cells (ECDI-SP) + anti-CD20 + Sirolimus) on xenotransplantation.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1455691","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:26:59Z","timestamp":1726187219000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Cutting edge of immune response and immunosuppressants in allogeneic and xenogeneic islet transplantation"],"prefix":"10.3389","volume":"15","author":[{"given":"Liting","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68341-4","article-title":"Type 1 diabetes","volume":"367","author":"Daneman","year":"2006","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000055","article-title":"Localized immunomodulation with PD-L1 results in sustained survival and function of allogeneic islets without chronic immunosuppression","volume":"204","author":"Batra","year":"2020","journal-title":"J Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.17.2254","article-title":"Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review","volume":"289","author":"DeWitt","year":"2003","journal-title":"Jama"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1293762","article-title":"Challenges and opportunities in the islet transplantation microenvironment: a comprehensive summary of inflammatory cytokine, immune cells, and vascular endothelial cells","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/db05-1423","article-title":"The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience","volume":"55","author":"Pambianco","year":"2006","journal-title":"Diabetes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/ajt.13667","article-title":"Pancreas","author":"Kandaswamy","year":"2016","journal-title":"Am J Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00000658-200104000-00003","article-title":"Lessons learned from more than 1,000 pancreas transplants at a single institution","volume":"233","author":"Sutherland","year":"2001","journal-title":"Ann Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i47.6347","article-title":"Transplantation for the treatment of type 1 diabetes","volume":"13","author":"Meloche","year":"2007","journal-title":"World J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2243-0","article-title":"Advancing islet transplantation: from engraftment to the immune response","volume":"54","author":"Gibly","year":"2011","journal-title":"Diabetologia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"451035","DOI":"10.1155\/2014\/451035","article-title":"Inflammatory response in islet transplantation","volume":"2014","author":"Kanak","year":"2014","journal-title":"Int J Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(05)81142-0","article-title":"Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota","volume":"166","author":"Sutherland","year":"1993","journal-title":"Am J Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.12.3288","article-title":"Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience","volume":"26","author":"Hirshberg","year":"2003","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200423235","article-title":"Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus","volume":"114","author":"Rother","year":"2004","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.178","article-title":"Clinical pancreatic islet transplantation","volume":"13","author":"Shapiro","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.7.1595","article-title":"Islet transplantation: a brave new world","volume":"52","author":"Ricordi","year":"2003","journal-title":"Diabetes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1517\/03009734000000059","article-title":"Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes","volume":"105","author":"Bennet","year":"2000","journal-title":"Ups J Med Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)12020-4","article-title":"Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation","volume":"360","author":"Moberg","year":"2002","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/tri.2017.30.issue-3","article-title":"Intraportal islet transplantation: the impact of the liver microenvironment","volume":"30","author":"Delaune","year":"2017","journal-title":"Transpl Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000098905.86445.0F","article-title":"Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation","volume":"76","author":"Moberg","year":"2003","journal-title":"Transplantation"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00811.x","article-title":"Leukocyte-endothelial interactions in inflammation","volume":"13","author":"Langer","year":"2009","journal-title":"J\u00a0Cell Mol Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15689","article-title":"P- and E- selectin in venous thrombosis and non-venous pathologies","volume":"20","author":"Purdy","year":"2022","journal-title":"J Thromb Haemost"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.849580","article-title":"The influence of microenvironment on survival of intraportal transplanted islets","volume":"13","author":"Yan","year":"2022","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.15189","article-title":"A metabolomic approach ((1)H HRMAS NMR spectroscopy) supported by histology to study early post-transplantation responses in islet-transplanted livers","volume":"12","author":"Vivot","year":"2016","journal-title":"Int J Biol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M307774200","article-title":"STAT1-induced apoptosis is mediated by caspases 2, 3, and 7","volume":"279","author":"Sironi","year":"2004","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.6.1779","article-title":"Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation","volume":"51","author":"Ozmen","year":"2002","journal-title":"Diabetes"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.55.04.06.db05-1048","article-title":"CD4+ CD25+ regulatory T-cells inhibit the islet innate immune response and promote islet engraftment","volume":"55","author":"Chen","year":"2006","journal-title":"Diabetes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005783","article-title":"Pancreas and islet transplantation: comparative outcome analysis of a single-centre cohort over 20-years","volume":"277","author":"Marfil-Garza","year":"2023","journal-title":"Ann Surg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0549","article-title":"Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes","volume":"63","author":"Rodriguez-Calvo","year":"2014","journal-title":"Diabetes"},{"key":"B30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4203","article-title":"Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes","volume":"22","author":"Babon","year":"2016","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00600-0","article-title":"Activation and regulation of alloreactive T cell immunity in solid organ transplantation","volume":"18","author":"Duneton","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/164_2021_557","article-title":"The biology and molecular basis of organ transplant rejection","volume":"272","author":"Halloran","year":"2022","journal-title":"Handb Exp Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5763430","DOI":"10.1155\/2019\/5763430","article-title":"The evolving roles of macrophages in organ transplantation","volume":"2019","author":"Li","year":"2019","journal-title":"J Immunol Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02155","article-title":"The immunological basis of liver allograft rejection","volume":"11","author":"Ronca","year":"2020","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15813","article-title":"Novel therapeutic opportunities afforded by plasma cell biology in transplantation","volume":"20","author":"Agarwal","year":"2020","journal-title":"Am J Transplant"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.humimm.2010.10.013","article-title":"Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival","volume":"72","author":"Ho","year":"2011","journal-title":"Hum Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.07.018","article-title":"De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation","volume":"33","author":"Morrell","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2002.00026.x","article-title":"Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction","volume":"3","author":"Le Moine","year":"2003","journal-title":"Am J Transplant"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2012.05.018","article-title":"CD4 T cells mediate cardiac xenograft rejection via host MHC Class II","volume":"31","author":"Plenter","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(06)72805-1","article-title":"Immunology of pancreatic islet transplantation","volume":"32","author":"Reffet","year":"2006","journal-title":"Diabetes Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4308-1","article-title":"Early prediction of autoimmune (type 1) diabetes","volume":"60","author":"Regnell","year":"2017","journal-title":"Diabetologia"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1675","article-title":"Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study","volume":"34","author":"Sun","year":"2011","journal-title":"Diabetes Care"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198510033131417","article-title":"Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure","volume":"313","author":"Soeldner","year":"1985","journal-title":"N Engl J Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198605223142106","article-title":"Type I diabetes mellitus. A chronic autoimmune disease","volume":"314","author":"Eisenbarth","year":"1986","journal-title":"N Engl J Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/9780470697405.ch7","article-title":"Type 1 diabetes: chronic progressive autoimmune disease","volume":"292","author":"Zhang","year":"2008","journal-title":"Novartis Found Symp"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2337\/diab.38.1.s85","article-title":"Recurrence of disease in pancreas transplants","author":"Sutherland","year":"1989","journal-title":"Diabetes"},{"key":"B49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2013.12.003","article-title":"CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes","volume":"50","author":"Sarikonda","year":"2014","journal-title":"J Autoimmun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1369\/0022155415576543","article-title":"Heterogeneity and lobularity of pancreatic pathology in type 1 diabetes during the prediabetic phase","volume":"63","author":"Rodriguez-Calvo","year":"2015","journal-title":"J Histochem Cytochem"},{"key":"B51","article-title":"Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases","volume":"53","author":"Sibley","year":"1985","journal-title":"Lab Invest"},{"key":"B52","article-title":"Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes","volume":"97","author":"Sutherland","year":"1984","journal-title":"Trans Assoc Am Physicians"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3109\/08916939709008024","article-title":"Immunogenetics and the cause of autoimmune disease","volume":"25","author":"Baxter","year":"1997","journal-title":"Autoimmunity"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.131","article-title":"Tolerance to islet autoantigens in type 1 diabetes","volume":"19","author":"Bach","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00007890-200001150-00018","article-title":"Serological markers of recurrent beta cell destruction in diabetic patients undergoing pancreatic transplantation","volume":"69","author":"Thivolet","year":"2000","journal-title":"Transplantation"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2217\/dmt.10.21","article-title":"Recurrence of autoimmunity in pancreas transplant patients: research update","volume":"1","author":"Pugliese","year":"2011","journal-title":"Diabetes Manag (Lond)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2008.03.459","article-title":"Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation","volume":"128","author":"Laughlin","year":"2008","journal-title":"Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0498","article-title":"Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells","volume":"59","author":"Vendrame","year":"2010","journal-title":"Diabetes"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2006.03244.x","article-title":"Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes","volume":"148","author":"Di Lorenzo","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.2.218","article-title":"Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes","volume":"49","author":"Braghi","year":"2000","journal-title":"Diabetes"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.12.1983","article-title":"Long-term function (6 years) of islet allografts in type 1 diabetes","volume":"46","author":"Alejandro","year":"1997","journal-title":"Diabetes"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119743","article-title":"Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids","volume":"100","author":"Delaunay","year":"1997","journal-title":"J Clin Invest"},{"key":"B63","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/00007890-199908150-00012","article-title":"Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation","volume":"68","author":"Drachenberg","year":"1999","journal-title":"Transplantation"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/00075198-200108000-00006","article-title":"Current immunosuppressant regimens: considerations for critical care","volume":"7","author":"Kahan","year":"2001","journal-title":"Curr Opin Crit Care"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2337\/diab.34.12.1309","article-title":"Effects of cyclosporine on glucose tolerance in the rat","volume":"34","author":"Yale","year":"1985","journal-title":"Diabetes"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200418050-00004","article-title":"Islet transplantation in patients with diabetes mellitus: choice of immunosuppression","volume":"18","author":"Nanji","year":"2004","journal-title":"BioDrugs"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198712000-00001","article-title":"Studies of the effects of FK506 on renal allografting in the beagle dog","volume":"44","author":"Ochiai","year":"1987","journal-title":"Transplantation"},{"key":"B68","article-title":"Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat","volume":"19","author":"Ochiai","year":"1987","journal-title":"Transplant Proc"},{"key":"B69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","article-title":"RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs","volume":"78","author":"Sabatini","year":"1994","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0106","article-title":"Evidence for rapamycin toxicity in pancreatic \u03b2-cells and a review of the underlying molecular mechanisms","volume":"62","author":"Barlow","year":"2013","journal-title":"Diabetes"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nat Cell Biol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2475-7","article-title":"Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2)","volume":"55","author":"Barlow","year":"2012","journal-title":"Diabetologia"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-030833","article-title":"Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML","volume":"109","author":"Zeng","year":"2007","journal-title":"Blood"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol Cell"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0874-4","article-title":"The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic \u03b2-cell mass: implications in the development of type-2 diabetes","volume":"69","author":"Xie","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0519","article-title":"Upregulation of the mammalian target of rapamycin complex 1 pathway by Ras homolog enriched in brain in pancreatic beta-cells leads to increased beta-cell mass and prevention of hyperglycemia","volume":"58","author":"Hamada","year":"2009","journal-title":"Diabetes"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00262.2009","article-title":"Critical roles for the TSC-mTOR pathway in \u03b2-cell function","volume":"297","author":"Mori","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01695-07","article-title":"Biphasic response of pancreatic beta-cell mass to ablation of tuberous sclerosis complex 2 in mice","volume":"28","author":"Shigeyama","year":"2008","journal-title":"Mol Cell Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/35050135","article-title":"Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice","volume":"408","author":"Pende","year":"2000","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1101\/gad.351605","article-title":"Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis","volume":"19","author":"Ruvinsky","year":"2005","journal-title":"Genes Dev"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0851","article-title":"Decreased IRS signaling impairs beta-cell cycle progression and survival in transgenic mice overexpressing S6K in beta-cells","volume":"59","author":"Elghazi","year":"2010","journal-title":"Diabetes"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M807458200","article-title":"mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability","volume":"284","author":"Balcazar","year":"2009","journal-title":"J Biol Chem"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31820c10c8","article-title":"Rapamycin impairs proliferation of transplanted islet \u03b2 cells","volume":"91","author":"Niclauss","year":"2011","journal-title":"Transplantation"},{"key":"B88","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1677\/JOE-09-0216","article-title":"Rapamycin impairs metabolism-secretion coupling in rat pancreatic islets by suppressing carbohydrate metabolism","volume":"204","author":"Shimodahira","year":"2010","journal-title":"J Endocrinol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/414807a","article-title":"Mitochondrial function in normal and diabetic beta-cells","volume":"414","author":"Maechler","year":"2001","journal-title":"Nature"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.195016","article-title":"Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate","volume":"286","author":"Gan","year":"2011","journal-title":"J Biol Chem"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.166991","article-title":"Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K\/Akt signaling","volume":"286","author":"Tato","year":"2011","journal-title":"J Biol Chem"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20081668","article-title":"mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)","volume":"416","author":"Garc\u00eda-Mart\u00ednez","year":"2008","journal-title":"Biochem J"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403260200","article-title":"A novel pathway of epithelial sodium channel activation involves a serum- and glucocorticoid-inducible kinase consensus motif in the C terminus of the channel's alpha-subunit","volume":"279","author":"Diakov","year":"2004","journal-title":"J Biol Chem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.2337\/db10-1194","article-title":"Rictor\/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size","volume":"60","author":"Gu","year":"2011","journal-title":"Diabetes"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200113785","article-title":"Islet beta cell expression of constitutively active Akt1\/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia","volume":"108","author":"Bernal-Mizrachi","year":"2001","journal-title":"J Clin Invest"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/nm1001-1133","article-title":"Regulation of pancreatic beta-cell growth and survival by the serine\/threonine protein kinase Akt1\/PKBalpha","volume":"7","author":"Tuttle","year":"2001","journal-title":"Nat Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208756200","article-title":"Protein kinase B\/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1)","volume":"277","author":"Wrede","year":"2002","journal-title":"J Biol Chem"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.2337\/db05-1000","article-title":"Pro- and antiapoptotic proteins regulate apoptosis but do not protect against cytokine-mediated cytotoxicity in rat islets and beta-cell lines","volume":"55","author":"Collier","year":"2006","journal-title":"Diabetes"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2008.02.019","article-title":"Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR","volume":"75","author":"Cai","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.5414\/CP202090","article-title":"Tacrolimus reversibly reduces insulin secretion, induces insulin resistance, and causes islet cell damage in rats","volume":"52","author":"Xu","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130770","article-title":"Tacrolimus- and sirolimus-induced human \u03b2 cell dysfunction is reversible and preventable","volume":"5","author":"Dai","year":"2020","journal-title":"JCI Insight"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1266","article-title":"and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents","volume":"99","author":"Pereira","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B104","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-017-0203-0","article-title":"Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure","volume":"15","author":"Lombardi","year":"2017","journal-title":"Cell Commun Signal"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24967","article-title":"Role of the forkhead protein FoxO1 in beta cell compensation to insulin resistance","volume":"116","author":"Okamoto","year":"2006","journal-title":"J Clin Invest"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14323","article-title":"Deciphering tacrolimus-induced toxicity in pancreatic \u03b2 Cells","volume":"17","author":"Tri\u00f1anes","year":"2017","journal-title":"Am J Transplant"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"B109","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/cells12050796","article-title":"No time to die-how islets meet their demise in transplantation","volume":"12","author":"Kale","year":"2023","journal-title":"Cells"},{"key":"B110","doi-asserted-by":"publisher","first-page":"109424","DOI":"10.1016\/j.intimp.2022.109424","article-title":"Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2\/STAT3 signaling","volume":"113","author":"Liu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1341314","article-title":"Advancements in innate immune regulation strategies in islet transplantation","volume":"14","author":"Duan","year":"2023","journal-title":"Front Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.1985.sp002920","article-title":"A morphometric study of the endocrine and exocrine capillaries of the pancreas","volume":"70","author":"Henderson","year":"1985","journal-title":"Q J Exp Physiol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/BF00192309","article-title":"The design and development of an immunosuppressive drug, mycophenolate mofetil","volume":"14","author":"Allison","year":"1993","journal-title":"Springer Semin Immunopathol"},{"key":"B114","article-title":"Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation","volume":"26","author":"Allison","year":"1994","journal-title":"Transplant Proc"},{"key":"B115","article-title":"The role of de novo purine synthesis in lymphocyte transformation","author":"Allison","year":"1977","journal-title":"Ciba Found Symp"},{"key":"B116","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.10.040192.002001","article-title":"Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction","volume":"10","author":"Rosenberg","year":"1992","journal-title":"Annu Rev Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200104270-00014","article-title":"Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group","volume":"71","year":"2001","journal-title":"Transplantation"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199806150-00007","article-title":"A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group","volume":"65","author":"Mathew","year":"1998","journal-title":"Transplantation"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.2000.140301.x","article-title":"Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics","volume":"14","author":"Pescovitz","year":"2000","journal-title":"Clin Transplant"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/348639a0","article-title":"Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages","volume":"348","author":"Hutchings","year":"1990","journal-title":"Nature"},{"key":"B122","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.90.19.8992","article-title":"Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process","volume":"90","author":"Corbett","year":"1993","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.4.706","article-title":"Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes","volume":"48","author":"Flodstr\u00f6m","year":"1999","journal-title":"Diabetes"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2009.21","article-title":"The role of inflammation in insulitis and beta-cell loss in type 1 diabetes","volume":"5","author":"Eizirik","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1749-6632.2012.06633.x","article-title":"Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction","volume":"1261","author":"Silverman","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119175","article-title":"Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets","volume":"99","author":"Lambillotte","year":"1997","journal-title":"J Clin Invest"},{"key":"B127","article-title":"Feasibility of localized immunosuppression: 1. Exploratory studies with glucocorticoids in a biohybrid device designed for cell transplantation","volume":"65","author":"Buchwald","year":"2010","journal-title":"Pharmazie"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2008.09.038","article-title":"Short-term glucocorticoid treatment increases insulin secretion in islets derived from lean mice through multiple pathways and mechanisms","volume":"301","author":"Hult","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1111\/tri.2008.21.issue-7","article-title":"Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo","volume":"21","author":"Lund","year":"2008","journal-title":"Transpl Int"},{"key":"B130","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1210\/en.2009-0704","article-title":"Glucocorticoids in vivo induce both insulin hypersecretion and enhanced glucose sensitivity of stimulus-secretion coupling in isolated rat islets","volume":"151","author":"Rafacho","year":"2010","journal-title":"Endocrinology"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1054","article-title":"Optimal elevation of \u03b2-cell 11\u03b2-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced \u03b2-cell failure","volume":"61","author":"Turban","year":"2012","journal-title":"Diabetes"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpa.0000203961.16630.2f","article-title":"Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes","volume":"32","author":"Balamurugan","year":"2006","journal-title":"Pancreas"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1188\/04.CJON.473-480","article-title":"Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications","volume":"8","author":"Colson","year":"2004","journal-title":"Clin J Oncol Nurs"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.2006.2.3.271","article-title":"Bortezomib (Velcadetrade mark) in the treatment of multiple myeloma","volume":"2","author":"Field-Smith","year":"2006","journal-title":"Ther Clin Risk Manag"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj309","article-title":"Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis","volume":"98","author":"Brignole","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1820","article-title":"NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145","volume":"107","author":"Vodanovic-Jankovic","year":"2006","journal-title":"Blood"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2118","article-title":"Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines","volume":"107","author":"Blanco","year":"2006","journal-title":"Blood"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3494","article-title":"Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation","volume":"108","author":"Nencioni","year":"2006","journal-title":"Blood"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401563101","article-title":"Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib","volume":"101","author":"Sun","year":"2004","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4526","article-title":"Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity","volume":"106","author":"Sun","year":"2005","journal-title":"Blood"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181bd7b3a","article-title":"Bortezomib can suppress activation of rapamycin-resistant memory T cells without affecting regulatory T-cell viability in non-human primates","volume":"88","author":"Kim","year":"2009","journal-title":"Transplantation"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2019.10.005","article-title":"A combination regimen of low-dose bortezomib and rapamycin prolonged the graft survival in a murine allogeneic islet transplantation model","volume":"216","author":"Hong","year":"2019","journal-title":"Immunol Lett"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2008.00743.x","article-title":"Rapamycin in islet transplantation: friend or foe","volume":"22","author":"Berney","year":"2009","journal-title":"Transpl Int"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0173","article-title":"Sirolimus is associated with reduced islet engraftment and impaired beta-cell function","volume":"55","author":"Zhang","year":"2006","journal-title":"Diabetes"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.1.247","article-title":"An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts","volume":"165","author":"Diamond","year":"2000","journal-title":"J Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199904150-00006","article-title":"Immune mechanisms associated with the rejection of fetal murine proislet allografts and pig proislet xenografts: comparison of intragraft cytokine mRNA profiles","volume":"67","author":"Simeonovic","year":"1999","journal-title":"Transplantation"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.10.076","article-title":"Cross-sensitization between xeno- and allo-antigens on subsequent allogeneic and xenogeneic pancreatic islet transplantation in a murine model","volume":"480","author":"Kim","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001489","article-title":"Differential role of B cells and IL-17 versus IFN-\u03b3 During early and late rejection of pig islet xenografts in mice","volume":"101","author":"Kang","year":"2017","journal-title":"Transplantation"},{"key":"B149","article-title":"Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon","volume":"7","author":"Cooper","year":"1988","journal-title":"J Heart Transplant"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2015.06.068","article-title":"Immunobiological barriers to xenotransplantation","volume":"23","author":"Cooper","year":"2015","journal-title":"Int J Surg"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cww088","article-title":"Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics","volume":"26","author":"Galili","year":"2016","journal-title":"Glycobiology"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s13353-014-0261-6","article-title":"The current state of xenotransplantation","volume":"56","author":"Zeyland","year":"2015","journal-title":"J\u00a0Appl Genet"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/nri2099","article-title":"Xenotransplantation: current status and a perspective on the future","volume":"7","author":"Yang","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4771-6_10","article-title":"Anti-Gal, alpha-Gal epitopes, and xenotransplantation","volume":"32","author":"Kobayashi","year":"1999","journal-title":"Subcell Biochem"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199108000-00006","article-title":"Immunopathology of hyperacute xenograft rejection in a swine-to-primate model","volume":"52","author":"Platt","year":"1991","journal-title":"Transplantation"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3089.2003.02092.x","article-title":"Pathology of xenograft rejection: a commentary","volume":"10","author":"Schuurman","year":"2003","journal-title":"Xenotransplantation"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.v27.i2","article-title":"Spectrum of the early xenograft response: from hyperacute rejection to delayed xenograft injury","volume":"27","author":"Ierino","year":"2007","journal-title":"Crit Rev Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1126\/science.1078942","article-title":"Production of alpha 1,3-galactosyltransferase-deficient pigs","volume":"299","author":"Phelps","year":"2003","journal-title":"Science"},{"key":"B159","doi-asserted-by":"publisher","first-page":"560850","DOI":"10.1155\/2011\/560850","article-title":"Alpha 1,3-galactosyltransferase deficiency in pigs increases sialyltransferase activities that potentially raise non-gal xenoantigenicity","volume":"2011","author":"Park","year":"2011","journal-title":"J Biomed Biotechnol."},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12091","article-title":"Xenoantibody response to porcine islet cell transplantation using GTKO, CD55, CD59, and fucosyltransferase multiple transgenic donors","volume":"21","author":"Chen","year":"2014","journal-title":"Xenotransplantation"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2009.05.001","article-title":"Pig-to-nonhuman primate islet xenotransplantation","volume":"21","author":"Hering","year":"2009","journal-title":"Transpl Immunol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12152","article-title":"Xenotransplantation: immunological hurdles and progress toward tolerance","volume":"258","author":"Griesemer","year":"2014","journal-title":"Immunol Rev"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199902150-00017","article-title":"CD4+ cells play a major role in xenogeneic human anti-pig cytotoxicity through the Fas\/Fas ligand lytic pathway","volume":"67","author":"Yi","year":"1999","journal-title":"Transplantation"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.2006.00348.x","article-title":"NK cells promote peritoneal xenograft rejection through an IFN-gamma-dependent mechanism","volume":"13","author":"Lin","year":"2006","journal-title":"Xenotransplantation"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200202150-00019","article-title":"CD4+ T cells initiate pancreatic islet xenograft rejection via an interferon-gamma-dependent recruitment of macrophages and natural killer cells","volume":"73","author":"Yi","year":"2002","journal-title":"Transplantation"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.6.3434","article-title":"Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses","volume":"164","author":"Lee","year":"2000","journal-title":"J Immunol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.2006.00297.x","article-title":"Lentiviral expression of CTLA4Ig inhibits primed xenogeneic lymphocyte proliferation and cytokine responses","volume":"13","author":"Mulley","year":"2006","journal-title":"Xenotransplantation"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000052594.83318.68","article-title":"Predominant expression of Th2 cytokines and interferon-gamma in xenogeneic cardiac grafts undergoing acute vascular rejection","volume":"75","author":"Singh","year":"2003","journal-title":"Transplantation"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1004175","article-title":"Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells","volume":"187","author":"Getts","year":"2011","journal-title":"J Immunol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103705","article-title":"Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance","volume":"189","author":"Kheradmand","year":"2012","journal-title":"J Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000802","article-title":"Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation","volume":"185","author":"Martin","year":"2010","journal-title":"J Immunol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.4.2212","article-title":"Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis","volume":"178","author":"Turley","year":"2007","journal-title":"J Immunol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e32834c2393","article-title":"Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment","volume":"16","author":"Nilsson","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000590","article-title":"Characterizing the mechanistic pathways of the instant blood-mediated inflammatory reaction in xenogeneic neonatal islet cell transplantation","volume":"2","author":"Liuwantara","year":"2016","journal-title":"Transplant Direct"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(00)00299-9","article-title":"CR3: a general purpose adhesion-recognition receptor essential for innate immunity","volume":"2","author":"Ehlers","year":"2000","journal-title":"Microbes Infect"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)04004-2","article-title":"The amplification loop of the complement pathways","volume":"104","author":"Lachmann","year":"2009","journal-title":"Adv Immunol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J Immunol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-011-0280-x","article-title":"Interactions between coagulation and complement\u2013their role in inflammation","volume":"34","author":"Oikonomopoulou","year":"2012","journal-title":"Semin Immunopathol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00565","article-title":"Deciphering the fine details of c1 assembly and activation mechanisms: \"mission impossible\"","volume":"5","author":"Gaboriaud","year":"2014","journal-title":"Front Immunol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2006.11.002","article-title":"Serine proteases of the classical and lectin pathways: similarities and differences","volume":"212","author":"G\u00e1l","year":"2007","journal-title":"Immunobiology"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J Immunol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.07.016","article-title":"Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy","volume":"217","author":"Ricklin","year":"2012","journal-title":"Immunobiology"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1309618110","article-title":"Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin","volume":"110","author":"Alcorlo","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M508928200","article-title":"The role of properdin in the assembly of the alternative pathway C3 convertases of complement","volume":"281","author":"Hourcade","year":"2006","journal-title":"J Biol Chem"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.06.002","article-title":"Properdin in complement activation and tissue injury","volume":"56","author":"Lesher","year":"2013","journal-title":"Mol Immunol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(00)00039-4","article-title":"Structure\/function of C5 convertases of complement","volume":"1","author":"Rawal","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1021\/bi500157z","article-title":"The making of a macromolecular machine: assembly of the membrane attack complex","volume":"53","author":"Bubeck","year":"2014","journal-title":"Biochemistry"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol Immunol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.2741\/e383","article-title":"Tissue factor in health and disease","volume":"4","author":"Williams","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-11-0771","article-title":"Tissue factor and thrombosis: The clot starts here","volume":"104","author":"Owens","year":"2010","journal-title":"Thromb Haemost"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.2174\/1381612820666141013154946","article-title":"Tissue factor and atherothrombosis","volume":"21","author":"Saha","year":"2015","journal-title":"Curr Pharm Des"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-264051","article-title":"Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis","volume":"116","author":"Kourtzelis","year":"2010","journal-title":"Blood"},{"key":"B195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0038-1646375","article-title":"The structural biology of expression and function of tissue factor","volume":"66","author":"Edgington","year":"1991","journal-title":"Thromb Haemost"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)47005-6","article-title":"The activation of prothrombin by the prothrombinase complex. The contribution of the substrate-membrane interaction to catalysis","volume":"269","author":"Walker","year":"1994","journal-title":"J Biol Chem"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01365.x","article-title":"Fibrinogen and fibrin structure and functions","volume":"3","author":"Mosesson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200003150-00007","article-title":"Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin","volume":"69","author":"Bennet","year":"2000","journal-title":"Transplantation"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.6.1755","article-title":"Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation","volume":"54","author":"Johansson","year":"2005","journal-title":"Diabetes"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1021\/bi00107a001","article-title":"The coagulation cascade: initiation, maintenance, and regulation","volume":"30","author":"Davie","year":"1991","journal-title":"Biochemistry"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(03)00250-0","article-title":"Current anticoagulant therapy\u2013unmet clinical needs","author":"Hirsh","year":"2003","journal-title":"Thromb Res"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12247","article-title":"Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway","author":"Bouwens","year":"2013","journal-title":"J Thromb Haemost"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-512764","article-title":"Biology of tissue factor pathway inhibitor","volume":"123","author":"Wood","year":"2014","journal-title":"Blood"},{"key":"B204","article-title":"Thrombomodulin structure and function","volume":"78","author":"Sadler","year":"1997","journal-title":"Thromb Haemost"},{"key":"B205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1612655","article-title":"Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin","volume":"85","author":"Mosnier","year":"2001","journal-title":"Thromb Haemost"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02210.x","article-title":"Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI","volume":"8","author":"Roussel","year":"2008","journal-title":"Am J Transplant"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182a95cbc","article-title":"Regulatory sequences of the porcine THBD gene facilitate endothelial-specific expression of bioactive human thrombomodulin in single- and multitransgenic pigs","volume":"97","author":"Wuensch","year":"2014","journal-title":"Transplantation"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.6002\/ect","article-title":"Thrombin-activatable fibrinolysis inhibitor is activated in an instant blood-mediated inflammatory reaction after intraportal islet transplant","volume":"12","author":"Wang","year":"2014","journal-title":"Exp Clin Transplant"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12722","article-title":"Control of IBMIR in neonatal porcine islet xenotransplantation in baboons","volume":"14","author":"Hawthorne","year":"2014","journal-title":"Am J Transplant"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31816b22f3","article-title":"Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation","volume":"85","author":"Tjernberg","year":"2008","journal-title":"Transplantation"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000114872.26990.4F","article-title":"Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets","volume":"77","author":"Goto","year":"2004","journal-title":"Transplantation"},{"key":"B212","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2337\/diabetes.51.1.66","article-title":"Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia","volume":"51","author":"Biarn\u00e9s","year":"2002","journal-title":"Diabetes"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.2007.00419.x","article-title":"Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies","volume":"14","author":"van der Windt","year":"2007","journal-title":"Xenotransplantation"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0476","article-title":"Current advances and travails in islet transplantation","volume":"58","author":"Harlan","year":"2009","journal-title":"Diabetes"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0033","article-title":"Clinical islet xenotransplantation: how close are we","volume":"61","author":"van der Windt","year":"2012","journal-title":"Diabetes"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.3727\/096368908787648092","article-title":"Isolating human islets of Langerhans causes loss of decay accelerating factor (CD55) on beta-cells","volume":"17","author":"Tai","year":"2008","journal-title":"Cell Transplant"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182106091","article-title":"The importance of tissue factor expression by porcine NICC in triggering IBMIR in the xenograft setting","volume":"91","author":"Ji","year":"2011","journal-title":"Transplantation"},{"key":"B218","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3727\/096368911X580563","article-title":"Tissue factor knockdown in porcine islets: an effective approach to suppressing the instant blood-mediated inflammatory reaction","volume":"21","author":"Ma","year":"2012","journal-title":"Cell Transplant"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000275401.80187.1e","article-title":"Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model","volume":"84","author":"Berman","year":"2007","journal-title":"Transplantation"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2009.41.11.084","article-title":"Effect of nicotinamide on early graft failure following intraportal islet transplantation","volume":"41","author":"Jung","year":"2009","journal-title":"Exp Mol Med"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2014.06.008","article-title":"Clinical porcine islet xenotransplantation under comprehensive regulation","volume":"46","author":"Matsumoto","year":"2014","journal-title":"Transplant Proc"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000000466","article-title":"Tolerance in xenotransplantation","volume":"22","author":"Yamada","year":"2017","journal-title":"Curr Opin Organ Transplant"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15763","article-title":"Rejection of xenogeneic porcine islets in humanized mice is characterized by graft-infiltrating Th17 cells and activated B cells","volume":"20","author":"Lee","year":"2020","journal-title":"Am J Transplant"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann Neurol"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737296","article-title":"Reciprocal generation of Th1\/Th17 and T(reg) cells by B1 and B2 B cells","volume":"37","author":"Zhong","year":"2007","journal-title":"Eur J Immunol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1002\/art.25015","article-title":"A novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice","volume":"60","author":"Zhong","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242435","article-title":"Intra-islet proliferation of cytotoxic T lymphocytes contributes to insulitis progression","volume":"42","author":"Graham","year":"2012","journal-title":"Eur J Immunol"},{"key":"B229","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.addr.2013.09.020","article-title":"Clinical application of microencapsulated islets: actual prospectives on progress and challenges","author":"Calafiore","year":"2014","journal-title":"Adv Drug Delivery Rev"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1038\/nmat4290","article-title":"Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates","volume":"14","author":"Veiseh","year":"2015","journal-title":"Nat Mater"},{"key":"B231","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1900\/RDS.2014.11.84","article-title":"Islet and stem cell encapsulation for clinical transplantation","volume":"11","author":"Krishnan","year":"2014","journal-title":"Rev Diabetes Stud"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00202","article-title":"The future of islet transplantation is now","volume":"5","author":"Bottino","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6391","article-title":"Optimal implantation site for pancreatic islet transplantation","volume":"95","author":"Merani","year":"2008","journal-title":"Br J Surg"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.3727\/096368908786991515","article-title":"The choice of anatomical site for islet transplantation","volume":"17","author":"Van Der Windt","year":"2008","journal-title":"Cell Transplant"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3211","article-title":"A prevascularized subcutaneous device-less site for islet and cellular transplantation","volume":"33","author":"Pepper","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000107","article-title":"Long-term function of islets encapsulated in a redesigned alginate microcapsule construct in omentum pouches of immune-competent diabetic rats","volume":"43","author":"Pareta","year":"2014","journal-title":"Pancreas"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-6364-5_25","article-title":"Microencapsulation in clinical islet xenotransplantation","volume":"1479","author":"Shimoda","year":"2017","journal-title":"Methods Mol Biol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90570-3","article-title":"Transplantation of porcine fetal pancreas to diabetic patients","volume":"344","author":"Groth","year":"1994","journal-title":"Lancet"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1038\/nm1375","article-title":"Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways","volume":"12","author":"Cardona","year":"2006","journal-title":"Nat Med"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1038\/nm1369","article-title":"Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates","volume":"12","author":"Hering","year":"2006","journal-title":"Nat Med"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02850.x","article-title":"Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets","volume":"9","author":"van der Windt","year":"2009","journal-title":"Am J Transplant"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12868","article-title":"Pig-to-monkey islet xenotransplantation using multi-transgenic pigs","volume":"14","author":"Bottino","year":"2014","journal-title":"Am J Transplant"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12145","article-title":"Glucose metabolism in pigs expressing human genes under an insulin promoter","volume":"22","author":"Wijkstrom","year":"2015","journal-title":"Xenotransplantation"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13345","article-title":"Long-term control of diabetes in immunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine islets","volume":"15","author":"Shin","year":"2015","journal-title":"Am J Transplant"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12283","article-title":"Safe use of anti-CD154 monoclonal antibody in pig islet xenotransplantation in monkeys","volume":"24","author":"Bottino","year":"2017","journal-title":"Xenotransplantation"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12293","article-title":"Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts","volume":"24","author":"Iwase","year":"2017","journal-title":"Xenotransplantation"},{"key":"B247","doi-asserted-by":"publisher","first-page":"11138","DOI":"10.1038\/ncomms11138","article-title":"Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft","volume":"7","author":"Mohiuddin","year":"2016","journal-title":"Nat Commun"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12196","article-title":"Justifying clinical trials for porcine islet xenotransplantation","volume":"22","author":"Ellis","year":"2015","journal-title":"Xenotransplantation"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0909024107","article-title":"Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts","volume":"107","author":"Potter","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2010.11.050","article-title":"Porcine islet amyloid polypeptide fragments are refractory to amyloid formation","volume":"585","author":"Zhang","year":"2011","journal-title":"FEBS Lett"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.3727\/000000006783981954","article-title":"Survival of microencapsulated islets at 400 days posttransplantation in the omental pouch of NOD mice","volume":"15","author":"Kobayashi","year":"2006","journal-title":"Cell Transplant"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1317561110","article-title":"Transplantation of human islets without immunosuppression","volume":"110","author":"Ludwig","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1455691\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:27:11Z","timestamp":1726187231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1455691\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":252,"alternative-id":["10.3389\/fimmu.2024.1455691"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1455691","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"article-number":"1455691"}}